References
- Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet. 2012;379(9822):1245–1255. doi:https://doi.org/10.1016/S0140-6736(11)61347-0.
- Lai EC, Lau WY. Spontaneous rupture of hepatocellular carcinoma: a systematic review. Arch Surg. 2006;141(2):191–198. doi:https://doi.org/10.1001/archsurg.141.2.191.
- Amin MB, Greene FL, Edge SB, et al. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging. CA Cancer J Clin. 2017;67(2):93–99. doi:https://doi.org/10.3322/caac.21388.
- Zheng YJ, Li DL, Luo, et al. Early versus delayed hepatectomy for spontaneously ruptured hepatocellular carcinoma: a systematic review and meta-analysis. J Invest Surg. 2020;34(11):1214–1222.
- Zhang W, Zhang ZW, Zhang BX, et al. Outcomes and prognostic factors of spontaneously ruptured hepatocellular carcinoma. J Gastrointest Surg. 2019;23(9):1788–1800. doi:https://doi.org/10.1007/s11605-018-3930-7.
- Chevret S, Trinchet JC, Mathieu D, et al. A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d’Etude et de Traitement du Carcinome Hepatocellulaire. J Hepatol. 1999;31(1):133–141. doi:https://doi.org/10.1016/S0168-8278(99)80173-1.
- Farinati F, Rinaldi M, Gianni S, et al. How should patients with hepatocellular carcinoma be staged? Validation of a new prognostic system. Cancer. 2000;89(11):2266–2273. doi:https://doi.org/10.1002/1097-0142(20001201)89:11<2266::AID-CNCR15>3.0.CO;2-0.
- Abbasi A, Bhutto AR, Butt N, et al. Corelation of serum alpha fetoprotein and tumor size in hepatocellular carcinoma. J Pak Med Assoc. 2012;62(1):33–36.
- Toyoda H, Kumada T, Tada T, et al. Tumor markers for hepatocellular carcinoma: simple and significant predictors of outcome in patients with HCC. Liver Cancer. 2015;4(2):126–136. doi:https://doi.org/10.1159/000367735.
- Kerdsuknirun J, Vilaichone V, Vilaichone RK. Risk factors and prognosis of spontaneously ruptured hepatocellular carcinoma in Thailand. Asian Pac J Cancer Prev. 2018;19(12):3629–3634. doi:https://doi.org/10.31557/APJCP.2018.19.12.3629.
- Zhu LX, Wang GS, Fan ST. Spontaneous rupture of hepatocellular carcinoma. Br J Surg. 1996;83(5):602–607. doi:https://doi.org/10.1002/bjs.1800830507.
- Cheung TT, Poon RT, Chok KS, et al. Management of spontaneously ruptured hepatocellular carcinomas in the radiofrequency ablation era. PLoS One. 2014;9(4):e94453. doi:https://doi.org/10.1371/journal.pone.0094453.
- Couinaud C. Liver anatomy: portal (and suprahepatic) or biliary segmentation. Dig Surg. 1999;16(6):459–467. doi:https://doi.org/10.1159/000018770.
- Fan ST, Mau Lo C, Poon RT, et al. Continuous improvement of survival outcomes of resection of hepatocellular carcinoma: a 20-year experience. Ann Surg. 2011;253(4):745–758. doi:https://doi.org/10.1097/SLA.0b013e3182111195.
- Fan ST, Lo CM, Lai EC, et al. Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma. N Engl J Med. 1994;331(23):1547–1552. doi:https://doi.org/10.1056/NEJM199412083312303.
- Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–213. doi:https://doi.org/10.1097/01.sla.0000133083.54934.ae.
- Balzan S, Belghiti J, Farges O, et al. The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg. 2005;242(6):824–828. discussion 828–9. doi:https://doi.org/10.1097/01.sla.0000189131.90876.9e.
- Song PP, Xia JF, Inagaki Y, et al. Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma. World J Gastroenterol. 2016;22(1):262–274. doi:https://doi.org/10.3748/wjg.v22.i1.262.
- Duvoux C, Roudot-Thoraval F, Decaens T, et al. Liver transplantation for hepatocellular carcinoma: a model including alpha-fetoprotein improves the performance of Milan criteria. Gastroenterology. 2012;143(4):986–994e3. quiz e14-5. doi:https://doi.org/10.1053/j.gastro.2012.05.052.
- Hameed B, Mehta N, Sapisochin G, et al. Alpha-fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria. Liver Transpl. 2014;20(8):945–951. doi:https://doi.org/10.1002/lt.23904.
- Grąt M, Krasnodębski M, Patkowski W, et al. Relevance of pre-transplant alpha-fetoprotein dynamics in liver transplantation for hepatocellular cancer. Ann Transplant. 2016;21:115–124. doi:https://doi.org/10.12659/AOT.894644.
- Pawlik TM, Delman KA, Vauthey JN, et al. Tumor size predicts vascular invasion and histologic grade: implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl. 2005;11(9):1086–1092. doi:https://doi.org/10.1002/lt.20472.
- Agopian VG, Harlander-Locke M, Zarrinpar A, et al. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients. J Am Coll Surg. 2015;220(4):416–427. doi:https://doi.org/10.1016/j.jamcollsurg.2014.12.025.
- She WH, Chan ACY, Cheung TT, et al. Survival outcomes of liver transplantation for hepatocellular carcinoma in patients with normal, high and very high preoperative alpha-fetoprotein levels. WJH. 2018;10(2):308–318. doi:https://doi.org/10.4254/wjh.v10.i2.308.
- Giannini EG, Sammito G, Farinati F, et al. Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: implications for its clinical use. Cancer. 2014;120(14):2150–2157. doi:https://doi.org/10.1002/cncr.28706.
- Peng SY, Chen WJ, Lai PL, et al. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations. Int J Cancer. 2004;112(1):44–50. doi:https://doi.org/10.1002/ijc.20279.
- Erstad DJ, Tanabe KK. Prognostic and therapeutic implications of microvascular invasion in hepatocellular carcinoma. Ann Surg Oncol. 2019;26(5):1474–1493. doi:https://doi.org/10.1245/s10434-019-07227-9.
- Katz SC, Shia J, Liau KH, et al. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma. Ann Surg. 2009;249(4):617–623. doi:https://doi.org/10.1097/SLA.0b013e31819ed22f.
- Chen JS, Huang JQ, Chen XL, et al. Risk factors associated with intraoperative major blood loss during resection of hepatocellular carcinoma. Hepatogastroenterology. 2015;62(140):790–793.
- Famularo S, Giani A, Di Sandro S, et al. Does the Pringle maneuver affect survival and recurrence following surgical resection for hepatocellular carcinoma? A western series of 441 patients. J Surg Oncol. 2018;117(2):198–206. doi:https://doi.org/10.1002/jso.24819.
- Lin N, Li J, Ke Q, et al. Does the intermittent Pringle maneuver affect the recurrence following surgical resection for hepatocellular carcinoma? A systematic review. PLoS One. 2020;15(3):e0229870. doi:https://doi.org/10.1371/journal.pone.0229870.
- Yamamoto M, Kobayashi T, Kuroda S, et al. Impact of postoperative bile leakage on long-term outcome in patients following liver resection for hepatocellular carcinoma. J Hepatobiliary Pancreat Sci. 2020;27(12):931–941.
- Lee HS, Choi GH, Kang DR, et al. Impact of spontaneous hepatocellular carcinoma rupture on recurrence pattern and long-term surgical outcomes after partial hepatectomy. World J Surg. 2014;38(8):2070–2078. doi:https://doi.org/10.1007/s00268-014-2502-6.
- Joliat GR, Labgaa I, Uldry E, et al. Recurrence rate and overall survival of operated ruptured hepatocellular carcinomas. Eur J Gastroenterol Hepatol. 2018;30(7):792–796. doi:https://doi.org/10.1097/MEG.0000000000001115.
- Yeh CN, Lee WC, Jeng LB, et al. Spontaneous tumour rupture and prognosis in patients with hepatocellular carcinoma. Br J Surg. 2002;89(9):1125–1129. doi:https://doi.org/10.1046/j.1365-2168.2002.02188.x.
- Mizuno S, Yamagiwa K, Ogawa T, et al. Are the results of surgical treatment of hepatocellular carcinoma poor if the tumor has spontaneously ruptured? Scand J Gastroenterol. 2004;39(6):567–570. doi:https://doi.org/10.1080/00365520410005135.
- Zou J, Li C, Chen Y, et al. Retrospective analysis of transcatheter arterial chemoembolization treatment for spontaneously ruptured hepatocellular carcinoma. Oncol Lett. 2019;18(6):6423–6430. doi:https://doi.org/10.3892/ol.2019.11037.
- Winokur RS, Talenfeld AD, Mozley PD, et al. Yttrium-90 microsphere radioembolotherapy in a patient with spontaneously ruptured hepatocellular carcinoma. Clin Imaging. 2016;40(1):167–169. doi:https://doi.org/10.1016/j.clinimag.2015.08.011.
- Anand AC, Acharya SK. New developments in the treatment of hepatocellular carcinoma: the concept of adjuvant and neoadjuvant chemotherapy. J Clin Exp Hepatol. 2021;11(3):284–287. doi:https://doi.org/10.1016/j.jceh.2021.04.003.